Wells Fargo’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,368,839
Closed -$291M 6741
2014
Q4
$291M Sell
1,368,839
-54,150
-4% -$10.8M 0.11% 214
2014
Q3
$254M Sell
1,422,989
-102,964
-7% -$17.1M 0.11% 232
2014
Q2
$258M Sell
1,525,953
-317,588
-17% -$49.4M 0.11% 234
2014
Q1
$229M Sell
1,843,541
-164,705
-8% -$20.1M 0.1% 250
2013
Q4
$223M Sell
2,008,246
-535,464
-21% -$51.1M 0.1% 258
2013
Q3
$230M Sell
2,543,710
-1,148,670
-31% -$103M 0.11% 232
2013
Q2
$311M Buy
+3,692,380
New +$383M 0.16% 156

Other funds holding AGN

Wells Fargo's AGN Position: Q1 2015 in Review

Wells Fargo sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,368,839 shares — an estimated $291M sold.

Wells Fargo first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $311M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Wells Fargo reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Wells Fargo sold 1,368,839 Allergan Inc shares in Q1 2015, an estimated $291M.
  • Wells Fargo first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Wells Fargo's Allergan Inc position peaked at $311M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.